Sharing Mayo Clinic

Stories from patients, family, friends and Mayo Clinic staff

Archive for November 26th, 2012

November 26th, 2012

Runner travels “cross-country” for experienced tumor-removal team

By Margaret Shepard, Communications Associate Margaret_Marie

Amy Haberman and Dr. Leibovich

Amy Haberman and Dr. Bradley Leibovich after the Twin Cities Marathon

Amy Haberman was diagnosed with a noncancerous tumor the size of a small football, lodged near her left kidney and colon. Her local physicians advised her to look for a medical center that specializes in teams of surgeons who can remove large tumors that have nerve involvement and a significant blood supply. While the tumor was slow growing, it was fatal if not removed.

Amy traveled from her home in California to Minnesota to meet with a team of Mayo Clinic doctors, including urologist Bradley Leibovich, M.D.

"We'd performed similar surgery before. We were optimistic we could remove Amy's tumor," says Dr. Leibovich. "Mayo Clinic has a large, collaborative surgical practice, and we are experienced at handling difficult cases referred from around the world." Read the rest of this entry »

View full entry · Comment on this

Tags: Amy Haberman, Bradley Leibovich M.D., Matthew Clark PhD, noncanerous tumor

November 26th, 2012

“Hopeful life” after surgery to remove rare brain tumor

By Margaret Shepard, Communications Associate Margaret_Marie

Jacob Harpel holding a guitar

Jacob Harpel is back to doing what he loves — including playing music.

When 7-year-old Jacob Harpel was diagnosed with a rare brain tumor, doctors told his parents, Koreen and Paul, that it was most likely noncancerous (benign) and slow-growing and recommended a wait-and-see approach to treatment. But with the tumor causing seizures and dizzy spells, the Harpels decided to seek a second opinion.

After extensive testing, a pediatric neurologist at Mayo Clinic in Rochester, Minn., recommended removing the tumor.

"We were told that with surgery, there was a 50 percent chance Jacob could have permanent peripheral vision deficits looking down and to the right, and a 50 percent chance he'd experience speech or comprehension deficits or both," says Koreen.

The wait-and-see approach carried risks of its own. Read the rest of this entry »

View full entry · Comment on this

Tags: Jacob Harpel, Matthew Clark PhD, Nicholas M. Wetjen M.D., pediatric brain tumors

Contact Us · Privacy Policy